Mollianne M. Murray

Statistics

Publications

Citations

306

H-Index

Active since

2005

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

The University of Texas Health Science Center at Houston

Michael E. DeBakey VA Medical Center

University of Houston

Mollianne M. Murray is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, molecular oncology, and cell signaling.

ORCID

Publications per year

2005–2023

Publications

Mammalian Target of Rapamycin Activator RHEB Is Frequently Overexpressed in Human Carcinomas and Is Critical and Sufficient for Skin Epithelial Carcinogenesis

Zhi Hong Lu, Mark B. Shvartsman, Andrew Y. Lee et al. · Cancer Research · 2010 · 94 citations · Full text

Life Sciences, Genetics, Carcinogenesis +5

Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling

Chenchu Lin, Alicia M. Blessing, Thomas L. Pulliam et al. · Oncogene · 2021 · 68 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

The Low Molecular Weight Cyclin E Isoforms Augment Angiogenesis and Metastasis of Human Melanoma Cells <i>In vivo</i>

Elise S. Bales, Lisa Mills, Nancy Milam et al. · Cancer Research · 2005 · 54 citations · Full text

Medicine, Cell Biology, Oncology +16

Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity

Dominik Awad, Pham Hong Anh Cao, Thomas L. Pulliam et al. · Cancer Research · 2023 · 28 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Anti-HER2 Antibody Trastuzumab Inhibits CDK2-Mediated NPAT and Histone H4 Expression via PI3K Pathway

Xiao-Feng Le, Isabelle Betrosian, Weiqun Mao et al. · Cell Cycle · 2006 · 26 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 8